$ASCLETIS-B (01672.HK)$ announced in partnership with Sagime...
$ASCLETIS-B(01672.HK$ announced in partnership with Sagimet Biosciences Inc. The first patient in its Phase IIb non-alcoholic steatohepatitis (NASH) clinical trial (fascinate-2) has been administered.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
cheez_lit : great to see that medicine in the world continues to improve